These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 501802)

  • 1. Mechanism of vaccinia virus release and its specific inhibition by N1-isonicotinoyl-N2-3-methyl-4-chlorobenzoylhydrazine.
    Payne LG; Kristenson K
    J Virol; 1979 Nov; 32(2):614-22. PubMed ID: 501802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of intracellular and extracellular vaccinia virus variants: N1-isonicotinoyl-N2-3-methyl-4-chlorobenzoylhydrazine interferes with cytoplasmic virus dissemination and release.
    Hiller G; Eibl H; Weber K
    J Virol; 1981 Sep; 39(3):903-13. PubMed ID: 7288920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of release of vaccinia virus by N1-isonicotinoly-N2-3-methyl-4-chlorobenzoylhydrazine.
    Kato N; Eggers HJ; Rolly H
    J Exp Med; 1969 Apr; 129(4):795-808. PubMed ID: 4974996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of cytochalasin D and monensin on enveloped vaccinia virus release.
    Payne LG; Kristensson K
    Arch Virol; 1982; 74(1):11-20. PubMed ID: 6891579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination.
    Wolffe EJ; Isaacs SN; Moss B
    J Virol; 1993 Aug; 67(8):4732-41. PubMed ID: 8331727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia.
    Payne LG
    J Gen Virol; 1980 Sep; 50(1):89-100. PubMed ID: 7441216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphogenesis and release of fowlpox virus.
    Boulanger D; Smith T; Skinner MA
    J Gen Virol; 2000 Mar; 81(Pt 3):675-87. PubMed ID: 10675404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mutation in the gene encoding the vaccinia virus 37,000-M(r) protein confers resistance to an inhibitor of virus envelopment and release.
    Schmutz C; Payne LG; Gubser J; Wittek R
    J Virol; 1991 Jul; 65(7):3435-42. PubMed ID: 2041074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of glycosylation inhibitors on the release of enveloped vaccinia virus.
    Payne LG; Kristensson K
    J Virol; 1982 Feb; 41(2):367-75. PubMed ID: 7077747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusion of intra- and extracellular forms of vaccinia virus with the cell membrane.
    Doms RW; Blumenthal R; Moss B
    J Virol; 1990 Oct; 64(10):4884-92. PubMed ID: 2398531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the vaccinia hemagglutinin polypeptide from a cell system yielding large amounts of extracellular enveloped virus.
    Payne LG
    J Virol; 1979 Jul; 31(1):147-55. PubMed ID: 501796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cell-associated enveloped vaccinia virus in cell-to-cell spread.
    Blasco R; Moss B
    J Virol; 1992 Jul; 66(7):4170-9. PubMed ID: 1602540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the vaccinia virus L1R myristylprotein as a component of the intracellular virion envelope.
    Ravanello MP; Hruby DE
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1479-83. PubMed ID: 8207414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adsorption and penetration of enveloped and naked vaccinia virus particles.
    Payne LG; Norrby E
    J Virol; 1978 Jul; 27(1):19-27. PubMed ID: 691111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-Dalton outer envelope protein.
    Blasco R; Moss B
    J Virol; 1991 Nov; 65(11):5910-20. PubMed ID: 1920620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Movements of vaccinia virus intracellular enveloped virions with GFP tagged to the F13L envelope protein.
    Geada MM; Galindo I; Lorenzo MM; Perdiguero B; Blasco R
    J Gen Virol; 2001 Nov; 82(Pt 11):2747-2760. PubMed ID: 11602786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polypeptide composition of extracellular enveloped vaccinia virus.
    Payne L
    J Virol; 1978 Jul; 27(1):28-37. PubMed ID: 691112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells and comet formation.
    Vanderplasschen A; Hollinshead M; Smith GL
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():2041-8. PubMed ID: 9267005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular release of enveloped vaccinia virus from mouse nasal epithelial cells in vivo.
    Payne LG; Kristensson K
    J Gen Virol; 1985 Mar; 66 ( Pt 3)():643-6. PubMed ID: 3973566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular enveloped vaccinia virus escapes neutralization.
    Ichihashi Y
    Virology; 1996 Mar; 217(2):478-85. PubMed ID: 8610439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.